KALA BIO Inc. (NASDAQ: KALA) jumped 37.87% to $0.88 in after-hours trading on Tuesday. Check out the current price of KALA stock here. According to Benzinga Pro data, the stock closed the regular ...

When you think of a night club, what do you imagine? Perhaps, dimmed lights, a heavy bass, and youngsters headbanging . You are close to the picture. Just replace the high- energy disco tracks with ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Arlington biotech Kala Bio has ...

If you thought Gen Z was only about EDM nights and late-night parties, it’s time to rethink. A new trend called ‘Bhajan Clubbing’ is redefining what club culture means for the youth today. Instead of ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Kala Pharmaceuticals ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Arlington biotech has been ...

Kala Bio said it laid off most of its employees after receiving notice that its lender, Oxford Finance, intends to foreclose on all of its remaining assets. The move follows the biotech company's ...

Kala Bio, Inc. (NASDAQ:KALA), a biotech company with a market capitalization of $10.74 million and showing significant stock volatility, announced it received a written notice of default from Oxford ...

Shares of Kala Bio plummeted Monday after the company said a study of its treatment for Persistent Corneal Epithelial Defect, an eye defect, missed its primary endpoints and it would stop development ...

(RTTNews) - KALA Bio, Inc. (KALA) on Monday announced that its CHASE Phase 2b study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED) did not meet the primary endpoint of ...

Sept 29 (Reuters) - Kala Bio (KALA.O), opens new tab will stop developing its experimental treatment for a type of eye condition after it failed to meet the main goal in a mid-stage study, sending the ...